Table 1.
Target IOP (mmHg) | Mono‐therapy n (%) | Multi‐therapy n (%) | ||||||
---|---|---|---|---|---|---|---|---|
All mono | Untreated IOP level | All multi | Untreated IOP level | |||||
<21 | 21 ≤ IOP ≤ 30 | ≥30 | <21 | 21 ≤ IOP < 30 | ≥30 | |||
n = 143 | n = 44 | n = 64 | n = 35 | n = 152 | n = 51 | n = 64 | n = 37 | |
<21 | 104 (73) | 40 (91) | 53 (83) | 11 (31) | 147 (97) | 51 (100) | 61 (95) | 35 (95) |
<18 | 70 (49) | 36 (82) | 29 (45) | 5 (14) | 140 (92) | 51 (100) | 58 (91) | 31 (84) |
<16 | 37 (26) | 24 (55) | 13 (20) | 0 | 120 (79) | 49 (96) | 47 (73) | 24 (65) |
<14 | 18 (13) | 15 (34) | 3 (5) | 0 | 102 (67) | 47 (92) | 36 (56) | 19 (51) |
<12 | 5 (3) | 5 (11) | 0 | 0 | 58 (38) | 26 (51) | 22 (34) | 10 (27) |
The eyes in both treatment arms were divided into three groups with respect to untreated IOP level.
IOP = intraocular pressure.